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The host transcriptome in feces was characterized in 259
rural Malawian children at risk for environmental enteric
dysfunction. A broad range of immune activation and de-
fects in cell adhesion were found, coupled with decreased
mucin expression, elucidating the pathobiology of this
condition.
BACKGROUND & AIMS: Environmental enteric dysfunction
(EED), a chronic diffuse inﬂammation of the small intestine, is
associated with stunting in children in the developing world.
The pathobiology of EED is poorly understood because of the
lack of a method to elucidate the host response. This study
tested a novel microarray method to overcome limitation of
RNA sequencing to interrogate the host transcriptome in feces
in Malawian children with EED.
METHODS: In 259 children, EED was measured by lactulose
permeability (%L). After isolating low copy numbers of host
messenger RNA, the transcriptome was reliably and repro-
ducibly proﬁled, validated by polymerase chain reaction.
Messenger RNA copy number then was correlated with %L and
differential expression in EED. The transcripts identiﬁed were
mapped to biological pathways and processes. The children
studied had a range of %L values, consistent with a spectrum of
EED from none to severe.
RESULTS: We identiﬁed 12 transcripts associated with the
severity of EED, including chemokines that stimulate T-cell
proliferation, Fc fragments of multiple immunoglobulin fam-
ilies, interferon-induced proteins, activators of neutrophils and
B cells, and mediators that dampen cellular responses to hor-
mones. EED-associated transcripts mapped to pathways related
to cell adhesion, and responses to a broad spectrum of viral,
bacterial, and parasitic microbes. Several mucins, regulatory
factors, and protein kinases associated with the maintenance of
the mucous layer were expressed less in children with EED
than in normal children.
CONCLUSIONS: EED represents the activation of diverse
elements of the immune system and is associated with wide-
spread intestinal barrier disruption. Differentially expressed
transcripts, appropriately enumerated, should be explored as
potential biomarkers. (Cell Mol Gastroenterol Hepatol
2016;2:158–174; http://dx.doi.org/10.1016/j.jcmgh.2015.12.002)Keywords: Environmental Enteropathy; Fecal Transcriptome;
Stunting; Intestinal Inﬂammation.
tunting, deﬁned as a height-for-age z score (HAZ) ofSless than -2, affects 26% of all children younger than
the age of 5 years worldwide.1,2 Stunting is associated with
reduced neurocognitive capability, diminished immuno-
competence, 20% of disability-adjusted life years lost in this
age group, and more than 2.1 million deaths annually.2
Optimal gut health encompasses effective dietary
nutrient absorption and a mucosal immune response that
conﬁnes microbes to the lumen without inducing chronic
tissue inﬂammation. Environmental enteric dysfunction
(EED) is an asymptomatic, diffuse villous atrophy of the
small bowel associated with chronic mucosal T-cell inﬁl-
tration and reduced paracellular integrity.3 EED is highly
prevalent, often without gastrointestinal symptoms, in poor
children in the developing world.4,5
EED typically is assessed with a dual sugar permeability
test, whereby mannitol (molecular weight, 182 daltons) and
lactulose (molecular weight, 342 daltons) are ingested un-
der controlled conditions and quantiﬁed in the urine. Both
sugars are neither degraded in the upper gastrointestinal
tract nor systemically metabolized after absorption, and are
excreted rapidly in the urine.6 Lactulose is a disaccharide,
which can be absorbed only by passively crossing disrupted
cell junctions, and thus the amount of this sugar in the urine
reﬂects small-bowel permeability.6,7 Mannitol, a mono-
saccharide, is absorbed across cell membranes and between
March 2016 EED Is Diverse Gut Inﬂammation and Repair 159cell junctions and is included to normalize lactulose uptake
and excretion to the mucosal surface area, and to control for
variations in gastric emptying time. Both the ratio of urinary
lactulose to mannitol and the fraction of lactulose that is
excreted in the urine (lactulose permeability [%L]) have
been used to assess gut health. The dual sugar assay,
although imperfect, is a theoretically sound measurement
test of gut health.7
Much has been learned about health and disease in the
past decade by using agnostic surveys of the human tran-
scriptome,8 including, in recent years, reliance on RNA deep
sequencing to proﬁle transcriptional response to injury.
Unfortunately, these methods have required RNA samples
larger than 1 mg that have been processed to remove in-
hibitors of nucleic acid hybridization and nonhuman RNA.
This requirement has limited our understanding of the host
transcriptome analyses of feces from individuals.
This report details the development and application to a
human cohort of a novel RNA selective isolation procedure
from human feces, coupled with high-density, whole human
transcriptome microarray technology to interrogate sam-
ples from 259 rural Malawian children with varying states
of EED.
Methods
Study Design
This was a prospective cohort observational study of
rural African children at high risk for EED. The primary
outcomes were the correlation between %L and expression
levels of protein coding genes, based on data that %L cor-
relates with linear growth in this population.9,10 Secondary
outcomes were associations with Kyoto Encyclopedia of
Genes and Genomes (KEGG) and canonical pathways in EED.
Eligible Subjects
The study was conducted in rural Malawi, where pop-
ulations practice subsistence farming (corn and beans), and
reside in mud and thatch homes. Water is collected from
boreholes and wells; electricity is unavailable. Inclusion
criteria consisted of subjects between 12 and 61 months of
age who reside in 1 of 6 rural communities under research
surveillance, and included 810 children in total.11–13 This
included a spectrum of children with EED, from no EED to
severe EED. Children were excluded if they had a chronic
disability or disease, severe acute malnutrition, or were
receiving therapy for tuberculosis. All subjects were inter-
viewed and examined by a physician and found to be free of
pathologic conditions. Weight, length, and mid-upper-arm
circumferences were measured by trained and monitored
staff to determine nutritional status.
Dual Sugar Absorption Testing
Dual sugar permeability testing was conducted in a su-
pervised setting, and complete consumption of the sugars
and collection of all urine during the subsequent 6 hours
was veriﬁed.12 Children consumed no food or drink for 8
hours before drinking 20 mL of water into which 1 g of
mannitol and 5 g of lactulose were dissolved. This wasadministered immediately after children voided. A dual
sugar permeability test was considered successfully
completed when all urine was collected for at least 4 hours
after ingestion of the sugars, without spillage of dosing
sugars or urine. Urine volumes were measured using a
graduated cylinder, and a 2-mL aliquot was ﬂash-frozen and
shipped to the Baylor College of Medicine (Houston, TX)
where urinary lactulose was measured using high-pressure
liquid chromatography.14,15 EED severity was assigned us-
ing population data from a larger clinical study such that the
children with %L less than 0.2 were designated as not
having EED, and those with %L greater than 0.2 and less
than 0.7 were designated as having intermediate EED, and
those with %L greater than 0.7 were designated as having
severe EED.9 The transformation log2 (%L*100) was used
to determine linear correlations between %L and micro-
array data.
Stool Collection
Fresh stools were collected before the dual sugar
absorption testing using a small, clean, nonabsorbent,
plastic diaper. The stools were transferred immediately to
cryovials and ﬂash-frozen in liquid nitrogen. Samples were
transferred to a -80C freezer and transported to Wash-
ington University (St. Louis, MO), where they then were
processed and analyzed for the human fecal transcriptome
as outlined in Figure 1 and detailed later.
Samples Chosen for Transcriptome Analyses
We chose 259 children for whole-transcriptome analysis
on the basis of a mannitol excretion greater than 3%, a total
urine volume greater than 15 mL, and a broad distribution
of urinary %L values, including normal children. The
mannitol was used as a test validation criterion because
very small amounts of mannitol absorption indicate very
rapid transit intestinal transit times, which distorts the
validity of %L as a measure of gut integrity.
Enriching Fecal Samples for Exfoliated
Enterocytes by Differential Centrifugation
Fecal samples were enriched for human cells by differ-
ential centrifugation before RNA extraction. Approximately
300–500 mg of frozen stool was transferred to a 15-mL
conical tube with 10–15 zirconium/silica beads (2.3 mm)
and 3 mL of Hank’s balanced salt solution (Gibco/Life
Technologies, Grand Island, NY) with 0.05% Tween-20
(Sigma, St Louis, MO). The samples were vortexed gently
for 5 minutes to suspend aggregates. The buffer volume was
increased to 10 mL and incubated at 4C on a rotator for 10
minutes, followed by centrifugation at 1000 rpm (500g) for
10 minutes. The supernatant was removed and the pellet
was resuspended in 10 mL of Hank’s balanced salt solution/
Tween-20 buffer and incubated and centrifuged as before.
Extracting and Assessing Enriched Fecal RNA
Total fecal nucleic acids were extracted from human-
enriched pellets and bacterial-enriched supernatants
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EasyMAG system (bioMérieux, Durham, NC).16–19 Co-
extracted DNA was removed with Baseline-ZERO DNase
(Epicentre, Madison, Wisconsin).20 Quantitative polymerase
chain reaction (qPCR) was performed using TaqMan assays
in a droplet digital PCR system (QX100; Bio-RadLaboratories, Inc, Hercules, CA).21–23 Human glyceraldehyde
3-phosphate dehydrogenase and bacterial 16S ribosomal
RNA (small subunit 16S ribosomal RNA) copies were
enumerated to assess the relative human and bacterial RNA
content compared with total nucleic acid mass (copies/ng).
Assaying the Human Fecal Transcriptome
on a High-Density Microarray
Human-enriched RNA extracted from differential
centrifugation pellets with a minimum of 15 glyceralde-
hyde 3-phosphate dehydrogenase copies/ng was used for
microarray assays. At least 100 ng of DNase-free fecal RNA
was ampliﬁed with the Ambion WT-plus kit (Ambion/Life
Technologies, Grand Island, NY) and hybridized to the
GeneChip Human Transcriptome Array 2.0 from Affymetrix
(Santa Clara, CA) following the manufacturer’s protocols.24
In total, 263 arrays were analyzed, consisting of samples
from 259 different individuals and 4 technical replicates.
Processing Microarray Signals Into Robust
Multi-Array Average, Iterative Rank Order
Normalization, and Factor Analyses For
Robust Microarray Summarization Data Sets
Raw off-scanner microarray intensity data were
normalized by 3 standard methods. The 3 methods differ in
their assumptions of data distribution and in the method
used for background processing, signal normalization, and
summarization.
First, robust multi-array average (RMA), the default
method, was performed in Affymetrix Expression Console,
and involves 3 steps: background correction, quantile
normalization, and median-polish summarization.25 RMA
output includes signal intensity values as well as probe-set
level detection P values, which ﬁlter out individual tran-
scripts with noisy low intensity level.Figure 1. Schematic ﬂow chart of human fecal tran-
scriptome analysis. Fecal samples were collected fresh from
subjects, immediately ﬂash-frozen in liquid nitrogen, and
transported to the laboratory. In the laboratory the cells were
suspended in buffer with inert beads and centrifuged at 500g.
The resulting pellet was kept, resuspended in lysis buffer, and
used for total nucleic acids extraction. DNase was added to
the nucleic acids mixture, and RNA was separated from the
suspension using a bead-based afﬁnity method. The RNA
then was ampliﬁed and hybridized to a chip containing
25mers covering the entire human genome. The signals
corresponding to luminescence for each 25mer were aggre-
gated into genes, and normalized using 3 standard methods.
Those transcripts that showed signiﬁcant correlation with %
L, a marker of EED, and differential expression with subsets
of increased and normal %L were identiﬁed. All transcripts
then were used to determine pathway expression for all ca-
nonical and KEGG pathways. Transcripts that were corre-
lated with %L, differentially expressed between children with
no EED and severe EED, and present in pathways also
associated with EED were considered to be of biological
signiﬁcance for EED. HTA, Human Transcriptome Array 2.0
(Affymetrix).
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libaffy version 2.1.5 (http://gene.mofﬁtt.org/libaffy), which
consists of RMA background correction, probe-level IRON,
the Tukey bi-weight summarization, and a ﬁnal probe-set or
transcript-level IRON.26 IRON normalizes through a gradu-
ally adjusted subset of invariant features (probe, probe-set,
or transcript/gene) in a pair-wise fashion; each individual
chip against the reference median chip, the one with the
smallest root-mean-square deviation in the data set. IRON
output includes only signal intensity values, and detection
calls rely upon the RMA method.
Third, factor analyses for robust microarray summari-
zation (FARMS) was performed using the R package FARMS,
and does not correct for background but does normalize to
quantiles.27 Because of an allocation memory issue inherited
in the FARMS software, we ran FARMS 10 times for each of
3 randomly grouped subgroups of 259 microarray samples
(ie, 30 runs in total). FARMS output includes informative/
noninformative calls for genes and probe-sets, in addition to
intensity values. The informative/noninformative calls can
be used to ﬁlter out poorly performing probe-sets and
transcripts in the data set.
RMA, IRON, and FARMS data sets each were ﬁltered to
exclude microRNA, open reading frame, nonprotein coding,
pseudogene, antisense, small nucleolar RNA, and unchar-
acterized RNA. Transcript clusters for high variable regions
of some genes localized on haplotype chromosomes and
unplaced contigs such as HLA antigen also were excluded
from the analysis. Final analysis thus was performed on 3
transcript-level data sets that each contained log-
transformed signal intensities for 18,646 known genes
that have a well-annotated ofﬁcial gene symbol.
Identifying Transcripts Associated With EED
by Correlation and Differential Expression
Transcripts correlated to the continuous variable %L
were identiﬁed by analysis of covariance to 257 normally
distributed log2-transformed %L values (2 outlier %L
values were removed from the total of 259 subjects) using
Partek Genomic Suite software, version 6.6 (Partek, Inc, St
Louis, MO). Differentially expressed transcripts were iden-
tiﬁed by analysis of variance between 60 healthy subjects
(%L < 0.2) and 42 with severe EED (%L > 0.7) using the R
package limma.28
Identifying KEGG and Canonical Pathways
Associated With EED
Transcripts that were correlated signiﬁcantly with %L
(analysis of covariance, P < .01) were used to identify ca-
nonical pathways associated with EED using the GeneGO
web tool MetaCore (Thomson Reuters version 6.21, build
66768, Philadelphia, PA).29
Fold-change data from differential expression analyses
of all transcripts were used to identify enriched KEGG
pathways using an R package generally applicable gene set/
pathway enrichment.30 All signiﬁcant pathways were
deﬁned minimally at P < .01, and a false discovery rate less
than 0.25.Interpreting Biologically Signiﬁcant
Transcripts and Pathways
Biological signiﬁcance was deﬁned as statistically sig-
niﬁcant associations between %L and the normalized
luminescence measurements in both IRON and RMA data
sets. Common transcripts associated with EED were iden-
tiﬁed by signiﬁcance in both correlation and differential
expression analyses in both IRON and RMA data sets, and
then ﬁltered to include only protein-coding genes detected
in more than 10% of the 259 arrays. Common pathways
associated with EED were deﬁned by enrichment in both
RMA and IRON data sets.
Transcripts that were associated with %L also were
tested for association with change in HAZ (dHAZ) over the
next 3 months, because one of the primary clinical interests
of EED is that it is associated with poor linear growth.
Growth data were available for 213 of the 259 subjects, and
Spearman correlation analysis was performed on 211 nor-
mally distributed dHAZ values (2 outlier dHAZ values were
removed) using Partek Genomic Suite software, version 6.6
(Partek, Inc).
Validation of Fecal Transcriptome Results
The reproducibility of microarray signals from fecal
extractions was validated with the 4 replicate arrays using the
Pearson correlation test and illustrated in scatter plots.
Furthermore, signal distribution was compared between fecal
microarray data and publicly available colon tissue micro-
array data (Affymetrix Sample Data)31 using the Kolmogor-
ov–Smirnov test and shown in histogram (Supplementary
Figure 1). Prior qPCR data for 42 genes were available for
at least 50 of the 259 subjects, and Pearson correlation
analysis was performed between qPCR and transcript level
microarray signals for RMA, IRON, and FARMS data sets to
validate normalization methods.21 Additional qPCR assays
were performed on 24 of the 51 transcripts identiﬁed by the
microarray as associated with EED to validate analysis results.
Results
Subjects
A total of 259 rural, asymptomatic, Malawian children at
risk for EED were studied (Table 1). The %L was associated
with reduced linear growth, expressed as dHAZ in the
subsequent 3-month period (Figure 2).
Human Fecal Messenger RNA Is Reproducibly
and Reliably Measured by Microarray
Expression of all transcripts was highly correlated
(Pearson r > 0.95) in replicate arrays regardless of the
normalization method (mean ± SD for RMA, 0.98 ± 0.00;
IRON, 0.96 ± 0.01; and FARMS, 1.00 ± 0.00), which is
comparable with Affymetrix reference microarray data from
colon biopsy specimens (Figure 3). Approximately 80% of
the 18,646 transcripts were detectable in at least 10% of
259 samples (Figure 3). More similarity between fecal and
colon tissue microarrays was observed in the distribu-
tion of signal in RMA and IRON data, than in FARMS
Table 1.Characteristics of Malawian Study Children at Risk
for Environmental Enteric Dysfunction
Characteristic
Mean ± SD
or N (%)
Male sex 134 (52)
Age, mo 30.1 ± 11.2
Weight-for-height, z score -0.1 ± 0.9
Height-for-age, z score -2.3 ± 1.2
Caretaker is mother 249 (96)
Father is alive 256 (99)
Siblings 3.2 ± 1.9
Individuals who sleep in the same
room as the child
3.1 ± 1.3
Home with a metal roof 67 (26)
Family owns a bicycle 147 (57)
Animals sleep in the house 118 (46)
Water from a clean source 206 (80)
Child uses pit latrine 125 (48)
Child has HIV infection 3 (1)
Mother reports child has loose stools 4 (2)
Lactulose:mannitol ratio 0.3 ± 0.2
Urinary lactulose, % dose administered 0.4 ± 0.3
Urinary mannitol, % dose administered 6.7 ± 3.0
EED severity
Healthy 60 (23)
Intermediate EED 157 (61)
Severe EED 42 (16)
HIV, human immunodeﬁciency virus.
Figure 2. Association between EED assessed with a dual
sugar absorption test and stunting in this population.
Relationship between %L excretion and linear growth,
expressed as the change in height-for-age Z-score in the
subsequent 3-month period. Data are expressed as means.
*Signiﬁcantly different means from normal children using the
Student t test with Tukey correction (P < .01). The green bar
represents children without EED showing excellent growth,
and the red bar represents children with severe EED showing
no growth.
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and FARMS, 0.654) (Figure 3). Microarray and qPCR signals
also were correlated highly in RMA and IRON normalized
data, with signiﬁcant correlations (P < .05) in 79% and 69%
of 42 genes tested, respectively, whereas FARMS signals
were less correlated to qPCR (Figure 4).Microarray Identiﬁed Biologically Relevant
Transcripts and Pathways Associated With EED
The numbers of transcripts that were correlated signif-
icantly to %L (P < .01) using either RMA or IRON signal
normalized data or those transcripts that were expressed
differentially (P < .05 and absolute value of fold-change >
1.1) between healthy subjects and those with severe EED
are summarized in Table 2. Further interpretation of bio-
logical signiﬁcance focused on those transcripts correlated
and expressed differentially in both IRON and RMA
normalized data sets because both were well validated by
qPCR, and indicated a higher similarity in data distribution
between good-quality colon RNA and degraded fecal RNA.
Fifty-one common signiﬁcant transcripts were identiﬁed as
correlated and expressed differentially in EED (Table 3).
The gene symbols are deﬁned and further descriptors of
these transcripts are listed in Supplementary Table 1.
Twenty-four of these also were tested by qPCR, and the 18
that were detectable all correlated highly to microarray
signals (Table 4).
Almost all of the 51 transcripts code for immunologically
active proteins, such as IgG or IgE, or for cytokines that
modulate the immune response. The molecules encoded
include proteins that are made in response to members of
various microbial kingdoms, including parasites, bacteria,
and viruses (Table 5). Among the 51 transcripts are 6 that
code for proteins that affect cell adhesion between epithelial
cells. There was a paucity of transcripts that code for
structural proteins or enzymes believed to be unique to the
small intestine.
Common pathways associated with EED were identiﬁed
by enrichment in both IRON and RMA data sets, and consist
of 6 GeneGO canonical pathways and 15 KEGG signaling
pathways (P < .01, false-discovery rate < 0.25) that are
related predominantly to cell adhesion and immunologic
responses (Figure 5 and Supplementary Tables 2 and 3). A
subset of 12 of the 51 common transcripts associated with
EED map to signiﬁcantly enriched common KEGG pathways
and include chemokines that stimulate T-cell proliferation,
Fc fragments of multiple immunoglobulin families,
interferon-induced proteins, activators of neutrophils and B
cells, and mediators that dampen cellular responses to
hormones (Table 6 and Figure 6).
Four mucins (MUC2, MUC4, MUC12, and MUC20),
epidermal growth factor receptor, and 3 mitogen-activated
protein kinases (MAPK7, MAPK8IP1, and MAPK8IP2),
were correlated negatively with %L (P < .05 for the
Pearson correlation coefﬁcient and the Spearman correla-
tion coefﬁcient using either the IRON or the RMA data set).
These 8 proteins, each of which are relevant to mucous
biology, are remarkable in that almost all of the other
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Figure 4. Correlation be-
tween qPCR data and the
normalized microarray
signals RMA and IRON.
Of the 42 transcripts that
were assessed by both
microarray and PCR, sig-
niﬁcant correlations were
found in 36 of them by one
or more normalization
methods. The transcripts
were not chosen simply for
their association with EED,
because some were not
associated, but to assess
the accuracy of the micro-
array across the spectrum
of protein coding genes.
Figure 3. (See previous page). Reproducibility and detectability of the microarray data using human fecal samples. (A)
Scatter plots of technical replicates showing high reproducibility of the microarray data generated using fecal RNAs. These
data were quite comparable with that generated using high-quality colon RNA (colon tissue RNAs were adopted from Affy-
metrix publicly available Sample Data). Note that the FARMS summarized data appears to show a substantial level of
compression. Conversely, a somewhat higher degree of variation was noted within the IRON normalized data. (B) Histogram of
signal detection level showing that microarray technology is reliable in the detection of low copy numbers of fecal RNAs. We
calculated the detection of transcript clusters (genes) based on the P values reported at probe-set level for intensity data (there
were no P values reported for the transcript cluster level of intensity data). At ﬁrst, the total number of detected multiple probe-
sets for a given transcript cluster was counted across the entire 259 chips at P < .05, then this number was divided by the total
number of multiple probe-sets on a chip for this given transcript cluster. Approximately 80% of the 18,646 known genes were
detectable in at least 10% of 259 samples.
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Table 2.Transcripts and Pathways Associated With Environmental Enteric Dysfunction Resulting From 3 Normalization and
Summarization Methods
Normalization
method
%L correlated
transcripts
Differentially expressed
transcripts
Enriched KEGG
pathways
Enriched canonical
pathways
Criteria for inclusion
ANCOVA
P < .01
ANOVA
P < .05 and
fold-change > 1.1
GAGE
P < .01 and
FDR < 0.25
MetaCore
P < .01 and
FDR < 0.25
RMA 637 (3.42%) 141 (0.76%) 17 (8.95%) 8 (4.97%)
IRON 667 (3.58%) 388 (2.08%) 19 (10.00%) 46 (28.57%)
FARMS 81 (0.43%) 12 (0.06%) 0 (0%) 17 (10.56%)
ANCOVA, analysis of covariance; ANOVA, analysis of variance; FDR, false-discovery rate; GAGE, generally applicable gene
set enrichment for pathway analysis; MetaCore, integrated software for functional analysis.
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scripts that are more abundant with EED. In addition, a
negative regulatory transcription factor in goblet
cells (recombination signal binding protein for immuno-
globulin kappa J region) shows a highly signiﬁcant corre-
lation with %L (P < .01).
Linear growth data over the subsequent 3 months after
stool sampling were available from 213 of the 259 children,
and expressed as dHAZ to normalize for age. Among the 51
common transcripts associated with %L, 17 also were
correlated with dHAZ after normalization with either RMA
or IRON (AQP9, CLEC7A, FCGR2A, FCGR3B, IFTM1, IFITM2,
IFTM3, LYN, LYZ, MNDA, MSN, NCF2, PLEK, PROK2, S100A8,
SAMSN1, and SELL) (Table 3). Among the 12 genes that
reside in KEGG pathways that are overexpressed, 6 of these
correlated with dHAZ.Discussion
In this study the human transcriptome was assessed in
individual fecal samples. Previously, host fecal RNA analyses
had been performed in samples that were aggregated from
similar subjects, to allow for larger amounts of RNA avail-
able for analyses32,33 or in analyses that targeted speciﬁc
loci.21,34 Our ﬁndings suggest that the 25mer, high-density
microarray technology coupled with careful fecal specimen
collection and a conservative RNA isolation method allows
for interrogation of the gut transcriptome. The extensive,
whole human transcriptome, nature of the read-outs, and
the ability to quantify signals and discern nonrandom
pathways lends credence to using transcript capture, rather
than sequencing or more tedious and potentially biased
speciﬁc transcript quantitative PCR, for host organ analysis
in stool.
The primary limitation of our methodology was that we
did not directly validate the read-outs with transcriptome
analyses from biopsy specimens. This would have been
impossible in rural Africa, and incompatible with the
ampliﬁcation we used on the fecal specimens. We did not
observe many reductions in genes and pathway expression
that were associated with EED; this might suggest that our
analyses were operating at the edge of the detection limit.Greater sensitivity might have allowed us to detect changes
in hormones and cytokines that adversely affect linear
growth, although it is not clear that the gut epithelium is
the site from which growth-affecting transcriptional re-
sponses are generated. We also recognize that out ﬁndings
are from rural African children consuming a plant-based
diet without public sanitation services, and we do not
know if these data and this technology can be applied to
other populations.
The greatest challenge in this work was to identify a
technique that would quantify components of the human
fecal transcriptome accurately, given the paucity of speciﬁc
human messenger RNA (mRNA) in any one sample. Host
mRNA is overwhelmed by a much larger population of
bacterial transcripts. Further RNA enrichment after extrac-
tion, using polyA selection and ribodepletion, did not in-
crease the sensitivity in our microarray method, and risked
the loss of target. We assume in addition to being present in
low numbers, human host transcripts were likely to be
fragmented, having passed through a potentially harsh
milieu in the gut. Perhaps by avoiding capture-based
enrichment early in the process, and using arrays as the
sole, end-preparation, hybridization step before enumera-
tion, we retained more of the fragments of human mRNAs.
This yield therefore might produce sufﬁcient human mRNAs
in our samples to anneal to the high-density microarray and
to provide reproducible transcript-level signals.
The bias introduced by sequence ampliﬁcation was a
limitation of our data. The low copy number present in
fecal samples requires ampliﬁcation to detect them
reproducibly by microarray. It is well known that ampli-
ﬁcation introduces bias on the basis of the probe length,
GC content of the probe, and hybridization preference for
certain sequences.35 These biases prevent us from
comparing our data with that from samples that do not
require ampliﬁcation, such as bowel biopsy specimens.
However, ampliﬁcation was applied equally to our entire
data set, thus comparisons between samples from children
with and without EED are likely to be informative. RNA
sequencing and microarray hybridization are methods
that both use ampliﬁcation, and thus both incur these
biases.
Table 3.Transcripts Associated With EED
Gene
symbol
Detected
in 259
Differential expression,
healthy vs severe EED
Pearson correlation
to %L
Spearman correlation
to dHAZ
FC/P value
(RMA)
FC/P value
(IRON)
r/P value
(RMA)
r/P value
(IRON)
rho/P value
(RMA)
rho/P value
(IRON)
ACSL1 26% 1.16/.006 1.27/.003 0.18/.004 0.19/.002 -0.05/.463 -0.05/.480
AMICA1 23% 1.12/.002 1.22/.000 0.20/.001 0.23/.000 -0.10/.148 -0.09/.218
AQP9 22% 1.33/.003 1.39/.004 0.17/.006 0.17/.007 -0.14/.038 -0.12/.083
ARRB2 42% 1.12/.009 1.14/.008 0.18/.003 0.18/.004 -0.04/.590 -0.07/.337
BCL2A1 26% 1.44/.003 1.45/.008 0.18/.004 0.18/.003 -0.09/.216 -0.12/.087
BCL6 21% 1.13/.005 1.16/.010 0.17/.007 0.18/.004 -0.07/.280 -0.10/.148
BIN2 30% 1.15/.002 1.23/.002 0.18/.004 0.20/.001 -0.10/.155 -0.06/.423
CD53 20% 1.20/.002 1.34/.001 0.17/.006 0.20/.001 -0.13/.063 -0.09/.186
CLEC7A 19% 1.11/.001 1.22/.001 0.20/.001 0.21/.001 -0.16/.018 -0.15/.033
CR1 16% 1.13/.001 1.23/.000 0.21/.001 0.24/.000 -0.06/.381 -0.02/.770
CSF2RB 18% 1.10/.010 1.14/.006 0.16/.010 0.18/.004 -0.07/.311 -0.09/.180
CSF3R 23% 1.12/.001 1.19/.000 0.22/.000 0.25/.000 -0.09/.176 -0.13/.059
CST7 36% 1.14/.001 1.18/.003 0.19/.002 0.18/.004 -0.10/.148 -0.12/.089
CXCR2 21% 1.16/.002 1.24/.001 0.17/.005 0.19/.002 -0.04/.529 -0.10/.165
FAM157A 24% 1.17/.018 1.22/.022 0.17/.005 0.16/.008 -0.04/.533 -0.03/.639
FAM157B 26% 1.13/.003 1.25/.001 0.19/.002 0.21/.001 0.03/.683 0.04/.579
FCER1G 24% 1.17/.002 1.29/.001 0.19/.002 0.21/.001 -0.08/.229 -0.12/.082
FCGR1B 19% 1.16/.003 1.25/.003 0.19/.002 0.18/.004 -0.07/.320 -0.05/.458
FCGR2A 25% 1.19/.002 1.31/.001 0.19/.002 0.19/.002 -0.15/.035 -0.14/.049
FCGR3B 23% 1.29/.002 1.39/.001 0.19/.002 0.18/.003 -0.18/.008 -0.20/.003
FFAR2 15% 1.33/.001 1.38/.002 0.19/.002 0.18/.005 -0.07/.311 -0.01/.887
FPR1 11% 1.24/.000 1.31/.000 0.19/.002 0.20/.002 -0.11/.116 -0.08/.240
GPR84 20% 1.11/.006 1.15/.015 0.16/.010 0.16/.009 -0.11/.097 -0.10/.143
IFI30 24% 1.24/.002 1.30/.002 0.20/.001 0.20/.001 -0.06/.378 -0.05/.461
IFITM1 41% 1.21/.001 1.32/.002 0.19/.002 0.20/.001 -0.19/.006 -0.18/.008
IFITM2 48% 1.42/.001 1.51/.001 0.20/.001 0.20/.001 -0.14/.041 -0.15/.024
IFITM3 45% 1.31/.001 1.38/.001 0.19/.003 0.20/.001 -0.11/.097 -0.16/.023
IL1RN 18% 1.14/.001 1.24/.002 0.17/.007 0.17/.005 -0.13/.057 -0.11/.106
LAPTM5 13% 1.24/.002 1.28/.004 0.18/.003 0.17/.005 -0.06/.423 -0.07/.328
LCP1 16% 1.17/.003 1.25/.003 0.19/.002 0.19/.002 -0.10/.153 -0.09/.201
LYN 26% 1.17/.008 1.27/.005 0.19/.003 0.19/.002 -0.14/.046 -0.15/.031
LYZ 22% 1.27/.000 1.41/.001 0.18/.004 0.17/.007 -0.10/.134 -0.16/.023
MNDA 30% 1.33/.004 1.52/.004 0.17/.007 0.17/.007 -0.18/.009 -0.18/.009
MSN 29% 1.11/.004 1.18/.002 0.17/.006 0.20/.001 -0.11/.114 -0.15/.030
NCF2 15% 1.20/.000 1.29/.000 0.24/.000 0.22/.000 -0.12/.080 -0.15/.034
NOP10 46% 1.12/.007 1.21/.001 0.17/.007 0.21/.001 0.00/.981 -0.13/.062
OR52D1 18% 1.13/.001 1.15/.022 0.24/.000 0.18/.005 -0.08/.278 -0.06/.401
PIK3AP1 24% 1.13/.004 1.22/.001 0.19/.002 0.21/.001 -0.01/.850 -0.06/.351
PLEK 39% 1.67/.003 1.56/.010 0.18/.003 0.17/.007 -0.14/.042 -0.11/.117
PROK2 26% 1.27/.000 1.34/.001 0.19/.003 0.18/.004 -0.08/.249 -0.14/.040
S100A12 10% 1.22/.006 1.31/.008 0.18/.004 0.17/.005 -0.10/.143 -0.08/.276
S100A8 27% 1.17/.004 1.39/.002 0.17/.008 0.18/.004 -0.13/.051 -0.14/.045
SAMSN1 24% 1.14/.022 1.30/.001 0.17/.005 0.21/.001 -0.12/.095 -0.18/.008
SDCBP 25% 1.20/.006 1.36/.009 0.19/.003 0.17/.006 -0.10/.148 -0.11/.118
SELL 19% 1.24/.001 1.43/.000 0.19/.002 0.24/.000 -0.15/.032 -0.16/.017
SLC2A3 26% 1.16/.006 1.25/.005 0.18/.004 0.18/.004 -0.12/.085 -0.13/.070
SOCS3 13% 1.12/.003 1.13/.005 0.18/.003 0.18/.004 -0.03/.627 -0.08/.277
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Table 3.Continued
Gene
symbol
Detected
in 259
Differential expression,
healthy vs severe EED
Pearson correlation
to %L
Spearman correlation
to dHAZ
FC/P value
(RMA)
FC/P value
(IRON)
r/P value
(RMA)
r/P value
(IRON)
rho/P value
(RMA)
rho/P value
(IRON)
SORL1 24% 1.17/.002 1.23/.005 0.20/.001 0.19/.002 -0.11/.101 -0.12/.094
TAGAP 23% 1.15/.007 1.24/.007 0.17/.008 0.19/.002 -0.10/.144 -0.07/.319
VNN2 18% 1.15/.002 1.25/.002 0.20/.001 0.21/.001 -0.11/.101 -0.12/.092
XPO6 21% 1.16/.002 1.21/.007 0.20/.002 0.19/.002 -0.04/.591 -0.06/.372
NOTE. Transcripts with differential expression: healthy %L less than 0.2 vs severe EED %L greater than 0.7; Pearson
correlations with %L; and Spearman correlation with change in height-for-age Z score in the subsequent 3-month period.
March 2016 EED Is Diverse Gut Inﬂammation and Repair 167We used the Affymetrix default data processing and
normalization algorithm (RMA-quantile) for our microarray
analysis. In light of the presumed degraded nature of fecal
RNAs, we also used 2 alternative, but complementary, signal
intensity normalization methods (IRON and FARMS) in our
analyses. RMA quantile normalization relies on the
assumption of Gaussian distributions of data, IRON per-
forms pair-wise intensity normalization without the
assumption of Gaussian distribution, and FARMS does notTable 4.Validation of 18 Common Transcripts Associated With
Target
N
(ddPCR)
Correlation between droplet
digital PCR and microarray (IRON
Spearman correlation
coefﬁcient/signiﬁcance
(2-tailed)
Pearson cor
coefﬁcient/sig
(2-taile
ACSL1 39 0.833/0.000 0.559/0.0
AQP9 39 0.699/0.000 0.636/0.0
BCL2A1 39 0.726/0.000 0.726/0.0
CD53 39 0.706/0.000 0.619/0.0
CSF3R 24 0.785/0.000 0.654/0.0
IFI30 39 0.698/0.000 0.467/0.0
IL1RN 36 0.801/0.000 0.743/0.0
LAPTM5 39 0.718/0.000 0.565/0.0
LCP1 33 0.835/0.000 0.583/0.0
LYN 39 0.833/0.000 0.531/0.0
LYZ 39 0.684/0.000 0.501/0.0
MNDA 25 0.775/0.000 0.513/0.0
PIK3AP1 39 0.802/0.000 0.741/0.0
PLEK 39 0.883/0.000 0.615/0.0
SELL 41 0.808/0.000 0.580/0.0
SLC2A3 33 0.761/0.000 0.557/0.0
SORL1 33 0.648/0.000 0.569/0.0
TAGAP 39 0.811/0.000 0.517/0.0
NOTE. Twenty-four targets were chosen for qPCR validation fr
were detectable. Pearson and Spearman correlations for all 18apply background subtraction but summarizes intensities of
probe-level based on a linear model with Gaussian noise and
Bayesian maximum a posteriori assumptions. FARMS iden-
tiﬁed just 12 signiﬁcant transcripts in the differential anal-
ysis and no signiﬁcant pathways in association with EED,
suggesting that when samples with low quantities of poor-
quality RNA are analyzed, meaningful data are lost when
summarizing signals based solely on a linear model.
Methods of signal normalization better suited forEED by Quantitative PCR: ddPCR
)
Correlation between
droplet digital PCR and microarray (RMA)
relation
niﬁcance
d)
Spearman correlation
coefﬁcient/signiﬁcance
(2-tailed)
Pearson correlation
coefﬁcient/signiﬁcance
(2-tailed)
00 0.818/0.000 0.607/0.000
00 0.725/0.000 0.669/0.000
00 0.743/0.000 0.763/0.000
00 0.753/0.000 0.648/0.000
01 0.746/0.000 0.798/0.000
03 0.701/0.000 0.478/0.002
00 0.739/0.000 0.632/0.000
00 0.690/0.000 0.644/0.000
00 0.837/0.000 0.584/0.000
01 0.843/0.000 0.532/0.000
01 0.672/0.000 0.535/0.000
09 0.778/0.000 0.496/0.012
00 0.843/0.000 0.714/0.000
00 0.885/0.000 0.666/0.000
00 0.802/0.000 0.611/0.000
01 0.710/0.000 0.626/0.000
01 0.694/0.000 0.656/0.000
01 0.841/0.000 0.57/0.000
om the 51 transcripts listed in Table 3. Of the 24 targets, 18
were highly signiﬁcant.
Table 5.Selected Functions of the 51 Transcripts Associated With EED
Gene
symbol Description
Cell
adhesion
Viral
response
Bacterial
response
Parasite
response
Fungal
response
Localized
to small
intestine
ACSL1 Acyl-CoA synthetase long-chain family member 1
AMICA1 Adhesion molecule, interacts with CXADR antigen 1 X X X
AQP9 Aquaporin 9 X
ARRB2 Arrestin, b 2 X
BCL2A1 BCL2-related protein A1 X X
BCL6 B-cell CLL/lymphoma 6 X
BIN2 Bridging integrator 2 X
CD53 CD53 molecule X X X X
CLEC7A C-type lectin domain family 7, member A X
CR1 Complement component (3b/4b) receptor 1
(Knops blood group)
X X X
CSF2RB Colony-stimulating factor 2 receptor, b, low-afﬁnity X X
CSF3R Colony-stimulating factor 3 receptor (granulocyte) X X X
CST7 Cystatin F (leukocystatin) X X
CXCR2 Chemokine (C-X-C motif) receptor 2 X X X
FAM157A Family with sequence similarity 157, member A
FAM157B Family with sequence similarity 157, member B
FCER1G Fc fragment of IgE, high-afﬁnity I, receptor for;
g polypeptide
X
FCGR1B Fc fragment of IgG, high-afﬁnity Ib, receptor (CD64) X X
FCGR2A Fc fragment of IgG, low-afﬁnity IIa, receptor (CD32) X X
FCGR3B Fc fragment of IgG, low-afﬁnity IIIb, receptor (CD16b) X X
FFAR2 Free fatty acid receptor 2 X X X
FPR1 Formyl peptide receptor 1 X
GPR84 G-protein–coupled receptor 84 X X X
IFI30 Interferon, g-inducible protein 30 X
IFITM1 Interferon-induced transmembrane protein 1 X
IFITM2 Interferon-induced transmembrane protein 2 X
IFITM3 Interferon-induced transmembrane protein 3 X
IL1RN Interleukin 1–receptor antagonist X X
LAPTM5 Lysosomal protein transmembrane 5 X
LCP1 Lymphocyte cytosolic protein 1 (L-plastin) X X X
LYN V-yes-1 Yamaguchi sarcoma viral-related
oncogene homolog
X X X
LYZ Lysozyme X
MNDA Myeloid cell nuclear differentiation antigen X
MSN Moesin X X
NCF2 Neutrophil cytosolic factor 2 X
NOP10 NOP10 ribonucleoprotein
OR52D1 Olfactory receptor, family 52, subfamily D, member 1
PIK3AP1 Phosphoinositide-3-kinase adaptor protein 1 X X
PLEK Pleckstrin
PROK2 Prokineticin 2 X
S100A12 S100 calcium binding protein A12 X X X X
S100A8 S100 calcium binding protein A8 X X X X
SAMSN1 SAM domain, SH3 domain and nuclear localization
signals 1
X X
SDCBP Syndecan binding protein (syntenin) X
SELL Selectin L X X
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Table 5.Continued
Gene
symbol Description
Cell
adhesion
Viral
response
Bacterial
response
Parasite
response
Fungal
response
Localized
to small
intestine
SLC2A3 Solute carrier family 2 (facilitated glucose
transporter), member 3
SOCS3 Suppressor of cytokine signaling 3 X X X X
SORL1 Sortilin-related receptor, L (DLR class)
A repeats containing
TAGAP T-cell activation RhoGTPase activating protein X
VNN2 Vanin 2 X
XPO6 Exportin 6
March 2016 EED Is Diverse Gut Inﬂammation and Repair 169interpretation of analyses from specimens with low tran-
script copy numbers need to be developed.
A framework to understand EED emerges from these
data, which is summarized in Figure 7. A disrupted mucous
layer allows luminal microbes to inﬂame the mucosa,
creating a chronic inﬂammatory state. The host response is
perpetuated by the steady stream of microbes present in the
contaminated environments of these rural African children.
A relatively high proportion of the transcripts showing a
correlation with EED (Table 6) are associated with myeloid
(monocyte, macrophage, dendritic cell, and neutrophil)
function. More speciﬁcally, a substantial number of these
genes are linked to granulocyte colony–stimulating factor
(G-CSF) signaling within these and other cell types. CSF 3
receptor is the primary high-afﬁnity receptor for G-CSF and
uses the Janus kinase/signal transducer and activator of
transcription and V-Yes-1 Yamaguchi Sarcoma Viral Related
Oncogene Homolog signal transduction pathways.36–39
Furthermore, SOCS3, BCL2A1, and CXCR2 are induced in
response to G-CSF activity. G-CSF pathway activation in-
cludes dendritic cell differentiation, neutrophil mobilization,
and, more generally, cell survival. G-CSF might protect
against infection and also serve survival/repair functions in
tissues including the intestine. Given the compromised
barrier cell junctions as well as the diffuse villous atrophy
observed in EED, it is quite plausible that the G-CSF increase
is a compensatory and appropriate response to microbial
threat because it augments defense against bacterial trans-
location and promotes villous repair.
The KEGG pathway analyses suggest that there are
immune responses to a diversity of microbes in EED. The role
of host–microbial interactions in the duodenum and jejunum
currently may be underappreciated because laboratory
methods of assessing the bacterial component of the micro-
biota, predominant in the colon, are so widely used. The
expression of genes and the activation of pathways, which
promote cell adhesion and phagocytosis, suggest that in EED
the host is endeavoring to clean up and repair damaged
paracellular junctions in the duodenum and jejunum. The
diversity of genes and pathways activated in EED support the
speculation that the etiology is multifactorial.40The diversity of immune responses found concurrently in
the transcriptome analyses suggests that the mucosa of the
small intestine is not shielded from the many microbes in the
gut lumen; this is in contrast to gut infections caused by a
particular microbe, during which we might expect to see a
stronger, more speciﬁc immune response. Goblet cells typi-
cally respond to inﬂammatory stimuli with increased mucus
secretion. We observed that there was a reduction in tran-
scripts coding for mucin, the protein core of the mucus layer,
and the protein kinases that confer the barrier properties to
the mucous layer. All of the mucin genes identiﬁed with
reduced expression are present in the small bowel.41,42 The
failure of rifaximin to ameliorate EED15 suggests that EED is
not simply a condition of overgrowth of bacteria in the small
intestine, or of infection with organisms susceptible to this
antibiotic. Taken together, these data support speculation
that EED is the result of, or at least accompanied by, inade-
quate mucus secretion of the duodenum and jejunum. Our
transcriptome ﬁndings are summarized in a cartoon in
Figure 7. In addition, penetration of the epithelial para-
cellular junctions by nonviable vesicles secreted by bacteria
evokes a strong inﬂammatory response, and this possibility
also should be considered in EED.43
Of the 51 transcripts in which there is increased
expression in EED, 29 are reported to respond to viral
infection. We speculate that virus presence and infection
might play a role in EED, and as our ability to characterize
and understand the role of viruses in the duodenum and
jejunum increases, researchers should investigate this
possibility further. Indeed, children from resource-poor
regions have a much more diverse intestinal virome
than those from high-income settings, and our data sug-
gest that the childhood gut might be responding to these
agents.44
The association of 33%–50% of the EED-associated
transcripts with subsequent linear growth is consistent
given the association with %L and linear growth in this
population.
Finally, the list of transcripts differentially expressed in
EED may provide direction to those seeking a better
biomarker for this elusive, formidable, scourge of children in
Figure 5. Association between environmental enteric dysfunction and inﬂammatory transcripts and pathways. (A)
Thirteen common KEGG pathways identiﬁed within both RMA- and IRON-normalized microarray intensity data. Numbers after
the titles of pathways in parentheses are the number of genes in the data set that were mapped to the given pathways. The
signiﬁcant genes shown are those with an absolute fold-change greater than 1.1 at P < .05 in differential analysis. The
percentage of up-regulation was calculated using mean fold-change values of signiﬁcant genes divided by mean fold-change
values of nonsigniﬁcant genes on the pathways. The -log10 (P value) was from pathway analysis, indicating the statistical
signiﬁcance. (B) There are 6 common canonical pathways identiﬁed using both IRON- and RMA-normalized microarray data.
The analysis was performed on genes with a signiﬁcant correlation between signal intensity and %L value at P < .01. The
numbers following the titles of pathways are the number of genes in the maps of given pathways. These pathways were
signiﬁcant at P < .01 and a false-discovery rate less than 0.25, and the log (P values) are shown in the dotted red lines. The
genes with positive correlation coefﬁcients are shown in gold, and the genes with negative correlation coefﬁcients are shown
in blue. COPD, chronic obstructive pulmonary disease; Fc, fragment crystallizable region; HIF-1, hypoxia-inducible factor 1;
NF, nuclear factor; NOD, nucleotide-binding oligomerization domain; RI, Fc epsilon RI or high-afﬁnity IgE receptor; TNF, tumor
necrosis factor.
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host transcriptome of the gastrointestinal tract through a
fecal specimen may be exploited to develop biomarkers for
other inﬂammatory and carcinogenic diseases of the gut in
the future. Our data also showed the feasibility and potential
superiority of direct from extract (ie, does not requireadditional treatment or manipulation as in previous pro-
tocols) immobilization of RNA on a support platform, on
which transcripts can be quantiﬁed directly. It is possible
that this methodology optimizes yield, and purity, of the
molecules of interest (ie, human mRNAs) in the complex
milieu of the fecal biomass.
Table 6.Transcripts Correlated With Environmental Enteric Dysfunction by Two Normalization Methods That Also Map to
KEGG Pathways
Gene
symbol Gene description
Pathway
category
r/P value
(IRON)
r/P value
(RMA)
BCL2A1 BCL2-related protein A1: retards apoptosis induced by interleukin
3 deprivation
Physiologic
stress
0.184/.003 0.181/.003
FCGR3B Fc fragment of IgG, low-afﬁnity IIIb, receptor (CD16b): binds to Fc region of
immunoglobulins gamma. Low-afﬁnity receptor. Binds complexed or
aggregated IgG and also monomeric IgG. Not capable of mediating
antibody-dependent cytotoxicity and phagocytosis
Phagocytosis 0.184/.003 0.189/.002
IFITM1 Interferon-induced transmembrane protein 1: antiviral protein that inhibits
the entry of viruses to the host cell cytoplasm, permitting endocytosis,
but preventing subsequent viral fusion and release of viral contents into
the cytosol. Active against multiple viruses
Response to
viral invasion
0.198/.001 0.188/.002
FCGR2A Fc fragment of IgG, low-afﬁnity IIa, receptor (CD32): binds to the Fc region
of IgG. Binds to IgG and initiates cellular responses against pathogens
and soluble antigens
Phagocytosis 0.190/.002 0.189/.002
NCF2 Neutrophil cytosolic factor 2: required for activation of the latent NADPH
oxidase
Phagocytosis 0.217/.001 0.237/.001
FCER1G Fc fragment of IgE, high-afﬁnity I, receptor for; g polypeptide:
the high-afﬁnity IgE receptor is a key molecule involved in allergic
reactions
Response to
viral invasion
0.214/.001 0.190/.002
LYN V-yes-1 Yamaguchi sarcoma viral-related oncogene homolog: nonreceptor
tyrosine-protein kinase. Plays an important role in the regulation of B-cell
differentiation, proliferation, survival, and apoptosis, and is important for
immune self-tolerance
Response to
infection
0.192/.002 0.187/.003
CXCR2 Chemokine (C-X-C motif) receptor 2: integral membrane proteins that
speciﬁcally bind and respond to cytokines of the CXC chemokine family.
Receptor for interleukin 8, which is a powerful neutrophil chemotactic factor.
Binds to interleukin 8 with high afﬁnity
Physiologic
stress
0.190/.002 0.173/.005
PIK3AP1 Phosphoinositide-3-kinase adaptor protein 1: signaling adapter that
contributes to B-cell development, controls excessive inﬂammatory
cytokine production by linking TLR signaling to PI3K activation
Response to
viral invasion
0.211/.001 0.188/.002
CLEC7A C-type lectin domain family 7, member A: functions as a pattern-recognition
receptor for a variety of b-1,3-linked and b-1,6-linked glucans, such as cell
wall constituents from pathogenic bacteria and fungi, and plays a role in innate
immune response. Stimulates T-cell proliferation
Phagocytosis 0.212/.001 0.201/.001
ARRB2 Arrestin, b 2: functions in regulating agonist-mediated desensitization of
G-protein–coupled receptor and cause speciﬁc dampening of cellular
responses to stimuli such as hormones, neurotransmitters, or sensory signals
Physiologic
stress
0.180/.004 0.182/.003
SOCS3 Suppressor of cytokine signaling 3: negative regulator of JAK/STAT pathway.
Inhibits cytokine signal transduction by binding to tyrosine kinase receptors
including gp130, LIF, erythropoietin, insulin, interleukin 12, G-CSF, and leptin
receptors
Physiologic
stress
0.181/.003 0.182/.003
JAK/STAT, Janus kinase/signal transducer and activator of transcription; LIF, leukemia inhibitory factor; NADPH, reduced
nicotinamide adenine dinucleotide phosphate; PI3K, phosphoinositide 3-kinase; TLR, Toll-like receptor.
Figure 6. Heat map for 12
common differentially
expressed signiﬁcant
genes, also mapped to
signiﬁcant KEGG path-
ways, correlated to %L in
both IRON- and RMA-
normalized microarray
expression data.
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Figure 7. Summary of the current understanding of the pathobiology of environmental enteric dysfunction. EED is
characterized by increased interaction between epithelial cells and microbes, resulting in changes in the architecture of the
small bowel and disruption of the barrier. This is a result of some disruption of the mucous layer, and potentially a dysbiosis
between commensal and pathogenic microbes, which include viruses. Multiple immune pathways are chronically activated by
this ongoing exposure. Nutrient absorption is reduced owing to the reduction in surface area of the epithelium and damage to
the absorptive villi. IEL, intraepithelial lymphocyte; NF, nuclear factor; NK, natural killer; NOD, nucleotide-binding oligomeri-
zation domain.
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Supplementary Figure 1. A comparison of transcript signal intensity and the transcript frequency in samples from colon
biopsies and fecal samples. Note that the distributions of transcripts at a given intensity are similar between both types of
samples using 3 different normalization methods, suggesting that these fecal samples are adequate for analyses.
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